Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel

The Pharmacogenomics Journal, Published online: 18 January 2021; doi:10.1038/s41397-020-00203-7Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel

Source: The Pharmacogenomics Journal - January 18, 2021 Category: Drugs & Pharmacology Authors: Caterina Vivaldi Stefania Crucitta Silvia Catanese Federico Cucchiara Elena Arrigoni Irene Pecora Eleonora Rofi Lorenzo Fornaro Francesca Salani Valentina Massa Enrico Vasile Riccardo Morganti Romano Danesi Marzia Del Re Source Type: research